IP Library › Granted Patent US 11,064,996
Granted Patent B2
US 11,064,996 · App. 16/291,498 · Granted Jul 20, 2021

Indirect attachment of a needle to a mesh suture

Inventor: Gregory A. Dumanian (Chicago, IL)
Assignee: NORTHWESTERN UNIVERSITY
A61B17/06166A61B17/06A61L17/00A61L17/04A61L17/12A61L17/145A61B2017/00526A61B2017/0412A61B2017/0417A61B2017/0461A61B2017/0464A61B2017/061A61B2017/0608A61B2017/06009A61B2017/06185Y10T29/49826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,064,996
App. No.
16/291,498
Granted
Jul 20, 2021
Kind
B2
Abstract

A medical device includes a surgical needle, an elongated suture, and an intervening segment. The elongated suture has a first end proximate to the needle and a second end located away from the needle. The elongated suture also includes a plurality of fibers defining a mesh wall between the first and second ends. A plurality of pores extend through the mesh wall, at least some which are in the macroporous size range of greater than 200 microns for facilitating tissue integration when introduced into a body. The intervening segment is disposed between and connected to either or both ends of the elongated suture and the needle. The intervening segment includes one or more fibers of the plurality of fibers and has a cross-sectional dimension smaller than a cross-sectional dimension of the mesh wall such that the intervening segment facilitates indirect attachment of the elongated macroporous mesh suture to the needle.

Claims (23)

1. A medical device comprising:

a surgical needle;

an elongate suture having a first end attached to the surgical needle and a second end located away from the surgical needle, the elongate suture including a plurality of fibers defining a mesh wall extending between the first end and the second end, and a plurality of pores extending through the mesh wall, wherein each of the pores has a pore size in a macroporous size range of 200 microns to 4 millimeters, and wherein the pores are adapted to facilitate tissue integration through the mesh wall when the elongate suture is introduced into a body; and

multiple intervening segments disposed between attaching the first end of the elongate suture and the surgical needle, wherein the multiple intervening segments are connected together to attach the surgical needle to the first end of the elongate suture.

2. The medical device of claim 1 , wherein the multiple intervening segments comprise:

a first intervening segment connected to the first end of the elongate suture; and

a second intervening segment connected to the surgical needle.

3. The medical device of claim 2 , wherein the first intervening segment comprises one or more fibers of the plurality of fibers extending from the first end of the mesh suture and having a cross-sectional dimension that is smaller than a cross-sectional dimension of the mesh wall.

4. The medical device of claim 3 , wherein the first intervening segment comprises more than one of the plurality of fibers converging into a bundled configuration.

5. The medical device of claim 4 , wherein at least some of the more than one fibers in the first intervening segment are fixed to each other via a process selected from the group consisting of annealed together, welded together, staked together, adhered together, bonded together, and loosely bonded together.

6. The medical device of claim 5 , wherein the more than one fibers are arranged in a configuration selected from the group consisting of (a) tapered from the mesh wall into the bundled configuration, (b) disposed in a braided configuration, (c) disposed in a knit configuration, and (d) disposed in a generally parallel configuration.

7. The medical device of claim 3 , wherein the first intervening segment further comprises one of a male or a female locking feature and the second intervening segment comprises the other of the male or the female locking feature for attaching to the first intervening segment.

8. The medical device of claim 7 , wherein the male and female locking features are constructed of rigid biocompatible material.

9. The medical device of claim 3 , wherein the second intervening segment comprises a collar having a first end into which the first intervening segment is secured and a second end into which a protrusion on the needle is secured.

10. The medical device of claim 1 , wherein the mesh wall of the elongate suture comprises a hollow tubular mesh wall defining a hollow core.

11. The medical device of claim 10 , wherein the hollow tubular mesh wall includes a diameter that is larger than a diameter of the multiple intervening segments.

12. The medical device of claim 11 , wherein the diameter of the hollow tubular mesh wall is in a range of 1 mm to 10 mm.

13. The medical device of claim 1 , wherein the mesh wall of the elongate suture comprises a planar mesh wall having a width and a thickness that is smaller than the width.

14. The medical device of claim 13 , wherein the width of the planar mesh wall is greater than a diameter of the intervening segment.

15. The medical device of claim 14 , wherein the width of the planar mesh wall is in a range of 1 mm to 10 mm.

16. The medical device of claim 1 , wherein the elongate suture is constructed of a material selected from the group consisting of: polyethylene terephthalate, nylon, polyolefin, polypropylene, silk, polymers p-dioxanone, co-polymer of p-dioxanone, ε-caprolactone, glycolide, L(−)-lactide, D(+)-lactide, meso-lactide, trimethylene carbonate, polydioxanone homopolymer, metal fibers, poly-4-hydroxybutyrate, steel, titanium, fibers derived from spider silk, graphene, and combinations thereof.

17. The medical device of claim 1 , wherein the mesh wall comprises a material selected from the group consisting of a woven material, a braided material, and a knitted material.

18. The medical device of claim 1 , wherein the elongate suture is at least 20 cm in length.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2020
From: DUMANIAN, GREGORY A., MR.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 051888/0380 →
Continuity (7)
Continuation 15825960 · Nov 29, 2017
Continuation In Part 15556831
Continuation In Part 14976864 · Dec 21, 2015
Continuation 13713665 · Dec 13, 2012
Provisional Application 62134099 · Mar 17, 2015
Provisional Application 61602183 · Feb 23, 2012
Related Publication 20190192142A1 · Jun 27, 2019
Cited By (1)
US 12,558,089